Clinical Trial Update: Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update regarding vitamin D3 to reduce cancer risk in postmenopausal women has completed Phase 2 and Phase 3 phases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Creighton University | Conditions: Cancer | Phase 2, Phase 3 | Status: COMPLETED